Related Experiment Video
Updated: Jul 5, 2025
11:31
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
8.6K
Cyclic GMP-AMP Synthase in Cancer Prevention
Weidong Chen1,2, Ga-Eun Lee1,2, Dohyun Jeung1,2
1BK21-Four, College of Pharmacy, The Catholic University of Korea.
Journal of Cancer Prevention
|January 11, 2024
Summary
Cyclic GMP-AMP synthase (cGAS) detects cytoplasmic DNA, initiating inflammatory responses via the cGAS-STING pathway. Inhibiting this pathway offers potential chemopreventive strategies by modulating cGAS activity.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Cyclic GMP-AMP (cGAMP) is a secondary messenger synthesized by cGAMP synthase (cGAS).
- cGAS activation by cytoplasmic DNA triggers the cGAS-STING signaling pathway, inducing inflammation and cytokine production.
- Cytoplasmic DNA can originate from damaged host DNA or microbial pathogens.
Purpose of the Study:
- To review the potential of modulating cGAS activity for therapeutic applications.
- To discuss the role of cGAMP as a secondary messenger.
- To explore the mechanism of self vs. foreign DNA discrimination by cGAS and its nuclear functions.
Main Methods:
- Literature review of cGAS-STING pathway.
- Analysis of cGAMP synthesis and function.
- Discussion of potential therapeutic targets within the pathway.
Main Results:
- The cGAS-STING pathway is a critical mediator of innate immunity and inflammation in response to cytoplasmic DNA.
- Modulating cGAS activity presents a promising avenue for developing chemopreventive agents.
- Understanding cGAS's DNA sensing mechanisms and nuclear roles is crucial for targeted interventions.
Conclusions:
- Targeting the cGAS-STING pathway holds significant therapeutic potential, particularly in inflammatory diseases and cancer chemoprevention.
- Further research into cGAS's precise functions and regulatory mechanisms is warranted.
- Inhibitors of the cGAS-STING pathway could offer novel treatment strategies.
More Related Videos
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:39Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:15M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K